|本期目录/Table of Contents|

[1]雷白,侯剑峰,胡盛寿.心脏术后心源性休克行体外膜肺氧合辅助后血液相容性不良事件的影响因素分析[J].国际心血管病杂志,2021,04:247-251.
　LEI Bai,HOU Jianfeng,HU Shengshou.Factors influencing the hemocompatibility related clinical adverse events after ECMO implantation in postcardiotomy cardiogenic shock patients[J].International Journal of Cardiovascular Disease,2021,04:247-251.
点击复制

心脏术后心源性休克行体外膜肺氧合辅助后血液相容性不良事件的影响因素分析(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2021年04期
页码:
247-251
栏目:
临床研究
出版日期:
2021-08-15

文章信息/Info

Title:
Factors influencing the hemocompatibility related clinical adverse events after ECMO implantation in postcardiotomy cardiogenic shock patients
作者:
雷白; 侯剑峰; 胡盛寿
100037 中国医学科学院阜外心血管病医院成人外科中心七病区,北京协和医学院
Author(s):
LEI Bai;  HOU Jianfeng;  HU Shengshou
Department of Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
关键词:
体外膜肺氧合;  血液相容性不良事件;  血液相容性评分;  心源性休克
Keywords:
Extra-corporeal membrane oxygenation;  Hemocompatibility related clinical adverse events;  Hemocompatibility score;  Cardiogenic shock
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2021.04.014
文献标识码:
-
摘要:
目的:探索心脏术后心源性休克行体外膜肺氧合辅助(ECMO)植入术后患者发生血液相容性不良事件(HRAEs)的特点及其影响因素。方法:回顾性分析2008年4月至2018年12月在北京阜外医院行心脏手术后发生心源性休克接受ECMO植入的280例患者,根据是否发生HRAEs分为HRAEs组(n=27)与对照组(n=253)。以血液相容性评分来确定HRAEs,采用Mann-Whitney U检验进行组间比较,用COX回归分析对ECMO植入术后患者HRAEs的影响因素进行分
Abstract:
Objective:To explore the related factors of hemocompatibility-related clinical adverse events(HRAEs)after extra-corporeal membrane oxygenation(ECMO)implantation in postcardiotomy cardiogenic shock(PCS)patients.Methods:A total of 280 PCS patients using ECM

参考文献/References

[1] Mehra MR. The burden of haemocompatibility with left ventricular assist systems: a complex weave[J]. Eur Heart J, 2019, 40(8):673-677.
[2] Mehra MR, Naka Y, Uriel N, et al. A fully magnetically levitated circulatory pump for advanced heart failure[J]. N Engl J Med, 2017, 376(5):440-450.
[3] 谢海秀, 杨峰, 江春景. 成人心脏术后心源性休克接受体外膜肺氧合循环辅助脱机后临床转归分析[J]. 中华医学杂志, 2017, 97(12):929-933.
[4] Rogers JG, Pagani FD, Tatooles AJ,et al. Intrapericardial left ventricular assist device for advanced heart failure[J]. N Engl J Med,2017,376(5):451-460.
[5] Mehra MR, Sundareswaran KS, Uriel N. Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure[J]. Circulation, 2017, 136(19):1872-1873.
[6] 何立芸, 牛杰. 成人体外膜肺氧合的应用及并发症[J].中国医学前沿杂志(电子版), 2019, 11(3):1-6.
[7] Mehta A, Ibsen LM. Neurologic complications and neurodevelopmental outcome with extra corporeal life support[J]. World J Crit Care Med, 2013, 2(4):40-47.
[8] Maltais S, Kilic A, Nathan S, et al. Prevention of Heart Mate Ⅱ pump thrombosis through clinical management: the PREVENT multi-center study[J]. J Heart Lung Transplant, 2017, 36:1-12.
[9] Sparrow CT, Nassif ME, Raymer DS, et al. Pre-operative right ventricular dysfunction is associated with gastrointestinal bleeding in patients supported with continuous-flow left ventricular assist devices[J]. JACC Heart Fail, 2015, 3(12):956-964.

备注/Memo

备注/Memo:
基金项目:科技部国家重点研发计划项目(2016YFC1300900)
通信作者:胡盛寿,E-mail:huss@fuwaihospital.org
更新日期/Last Update: 2021-08-15